Quarterly report · Q2
4578.TEDINET S100OUL3
Period2022-01-01 → 2022-06-30
Filed2022-08-03
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥814.3bn | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥434.0bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥1.50T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥718.8bn | 2021-01-01 → 2021-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥382.0bn | 2021-04-01 → 2021-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥67.1bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥46.4bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥111.2bn | 2021-01-01 → 2021-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥61.1bn | 2021-04-01 → 2021-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥92.8bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.8bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥163.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥119.2bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.2bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥69.8bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥46.5bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥125.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥91.4bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥46.7bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥71.5bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥47.3bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥93.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥48.0bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥3.10T | at 2022-06-30 | Cons. | Assets IFRS |
| Total assets | ¥2.82T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.73T | at 2021-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥839.5bn | at 2022-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥775.7bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.26T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.05T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.00T | at 2021-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.88T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥2.23T | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.01T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.97T | at 2021-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥456.8bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥410.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥426.5bn | at 2021-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥356.9bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥118.8bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥228.9bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥127.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥56.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥95.3bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥19.4bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥48.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥95.8bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥48.7bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥128.58 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥85.7 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥231.32 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥168.53 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥86.14 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥128.54 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥85.65 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥231.15 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥167.68 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥85.29 | 2021-04-01 → 2021-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 71.8% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.3% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 72.0% | at 2021-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 88
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥82.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥43.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥62.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥32.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥20.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥11.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | ¥7.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥3.8bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥20.1bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥11.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥20.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥11.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥22.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥11.1bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥16.7bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥9.0bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥16.7bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥9.0bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥5m |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2m |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥205.8bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥115.4bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥205.8bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥115.4bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥11m |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥7m |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥28.1bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥16.9bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥529.3bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥277.2bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥529.3bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥277.2bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥52.2bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥34.9bn |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥834.4bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥445.3bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥814.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥434.0bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥20.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥11.3bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥90.0bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥57.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-06-30 | ¥73.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥38.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-06-30 | ¥55.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥28.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥18.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥10.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | ¥9.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | ¥4.3bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-06-30 | −¥18.1bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥10.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-06-30 | −¥18.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥10.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥21.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥10.9bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥15.2bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥8.4bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥15.2bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥8.4bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥9m |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥5m |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥175.3bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥98.5bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥175.3bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥98.4bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥20m |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥11m |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥26.8bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥18.1bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥472.5bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥247.1bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥472.5bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥247.1bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥93.5bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥48.4bn |
| —segment total | revenue | 2021-01-01 → 2021-06-30 | ¥736.9bn |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥392.0bn |
| —segment total | revenue external | 2021-01-01 → 2021-06-30 | ¥718.8bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥382.0bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥18.1bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥10.0bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥133.0bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥72.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 858
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 410684000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 557835617 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 557835617 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 557835617 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 557835617 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 72124000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1329 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 56229000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1036 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 27514000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0507 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 23316000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0429 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 13059000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0240 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 10970000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0202 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 8642000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0159 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 8167000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0150 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 7936000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0146 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 7380000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0136 | |
| Number of shares held | CurrentQuarterInstant | 235340000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4337 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 15201800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 542465600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 5424656 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 168217 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 557835617 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 5424656 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 15201800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 15201800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0272 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 15201800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 15201800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0272 | |
| Cash and cash equivalents IFRS | Prior1YearInstant | 410684000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 456759000000 | JPY |
| Trade and other receivables2 ca IFRS | Prior1YearInstant | 380191000000 | JPY |
| Trade and other receivables2 ca IFRS | CurrentQuarterInstant | 389657000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 180350000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |